StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$2.51M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.51M–
FY2024Dec 31, 2024-$1.65M–
FY2023Dec 31, 2023-$2.40M–

More NewcelX figures

See a number that looks wrong?